Arkolith/Insider Trading/ACRS/Form 4

Loerop James

Chief Business OfficerAclaris Therapeutics, Inc. (ACRS) · full profile →Form 4 · filed Jan 5, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2026Tax withholding(F)6K$2.88$18K155K
Jan 2, 2026Option exercise(M)18K——161K
Dec 31, 2025Tax withholding(F)34K$3.01$102K143K
Dec 31, 2025Option exercise(M)74K——177K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2026Option exercise(M)18K—$019K
Dec 31, 2025Option exercise(M)74K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001781549-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML